| Pharmacokinetic, pharmacogenetic, and other factors influencing CNS penetration of antiretrovirals JN Nwogu, Q Ma, CP Babalola, WA Adedeji, GD Morse, B Taiwo AIDS Research and Treatment 2016, 2016 | 33 | 2016 |
| Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation P Leger, S Chirwa, JN Nwogu, M Turner, DM Richardson, P Baker, ... Pharmacogenetics and genomics 28 (1), 1-6, 2018 | 11 | 2018 |
| Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria JN Nwogu, M Gandhi, A Owen, SH Khoo, B Taiwo, A Olagunju, B Berzins, ... Aids 35 (12), 1919-1927, 2021 | 10 | 2021 |
| Willingness to donate hair samples for research among people living with HIV/AIDS attending a tertiary health facility in Ibadan, Nigeria JN Nwogu, CP Babalola, SO Ngene, BO Taiwo, B Berzins, M Gandhi AIDS research and human retroviruses 35 (7), 642-648, 2019 | 7 | 2019 |
| High acceptability of donating hair and other biological samples for research among people living with HIV in an outpatient clinic in Lagos, Nigeria EC Herbertson, CD Lahiri, JN Nwogu, RO Soremekun, OA Olugbake, ... AIDS Research and Human Retroviruses 37 (9), 676-682, 2021 | 5 | 2021 |
| Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria JN Nwogu, SO Ngene, CP Babalola, A Olagunju, A Owen, SH Khoo, ... AIDS Research and Therapy 19 (1), 35, 2022 | 3 | 2022 |
| Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle‐cell disease patients and healthy controls in Nigeria OE Adejumo, TR Kotila, AG Falusi, BO Silva, JN Nwogu, PS Fasinu, ... Pharmacology Research & Perspectives 4 (5), e00252, 2016 | 2 | 2016 |
| Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry A Olagunju, J Nwogu, O Eniayewu, S Atoyebi, A Amara, J Kpamor, ... Wellcome open research 6, 2021 | | 2021 |
| Effect of fixed-dose sizes on in vitro properties of artemether-lumefantrine tablets OA Odeniran, OO Obodozie-Ofoegbu, JN Nwogu, CP Babalola Journal of Pharmacy & Bioresources 15 (2), 188-196, 2018 | | 2018 |
| Effects of antacids on the pharmacokinetics of lumefantrine in healthy volunteers: A pilot study. CP Babalola African Journal of Medicine and Medical Sciences 47 (2), 161-169, 2018 | | 2018 |
